Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Dou

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Medcomm|December 1, 2025
Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary SyndromeHui-Hui Liu, Chen-Xi Song, Sha Li, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Journal of Geriatric Cardiology : JGC|July 1, 2024
The effect of fasting plasma glucose on in-hospital mortality after acute myocardial infarction in patients with and without diabetes: findings from a prospective, nationwide, and multicenter registryRui Fu, Ying-Xuan Zhu, Kong-Yong Cui, et al.
Chinese Medical Journal|May 26, 2010
Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registryKe-Fei Dou, Bo Xu, Yue-Jin Yang, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up resultsBo Xu, Ke-fei Dou, Ya-ling Han, et al.
Chinese Medical Journal|May 9, 2013
Can "Hybrid stent implantation" improve long-term safety without adversely affecting efficacy when treating multilesion coronary artery disease in the drug-eluting stent era?Dong Zhang, Bo Xu, Ke-fei Dou, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|April 12, 2012
[Clinical outcome of patients undergoing emergent coronary artery bypass grafting following failed percutaneous coronary intervention in stent era]Han-jun Pei, Yong-jian Wu, Yue-jin Yang, et al.
Chinese Medical Journal|January 19, 2010
Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center databaseRun-lin Gao, Bo Xu, Ji-lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|October 12, 2013
[Clinical outcomes of rotational atherectomy followed by drug-eluting stenting via the transradial approach for the treatment of heavily calcified coronary lesions]Jin-gang Cui, Yue-jin Yang, Yong-jian Wu, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Medcomm|December 1, 2025
Lipoprotein(a), ABO Blood Types and Clinical Outcomes: Novel Findings and Clinical Implications in Patients With Chronic Coronary SyndromeHui-Hui Liu, Chen-Xi Song, Sha Li, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Journal of Geriatric Cardiology : JGC|July 1, 2024
The effect of fasting plasma glucose on in-hospital mortality after acute myocardial infarction in patients with and without diabetes: findings from a prospective, nationwide, and multicenter registryRui Fu, Ying-Xuan Zhu, Kong-Yong Cui, et al.
Chinese Medical Journal|May 26, 2010
Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registryKe-Fei Dou, Bo Xu, Yue-Jin Yang, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up resultsBo Xu, Ke-fei Dou, Ya-ling Han, et al.
Chinese Medical Journal|May 9, 2013
Can "Hybrid stent implantation" improve long-term safety without adversely affecting efficacy when treating multilesion coronary artery disease in the drug-eluting stent era?Dong Zhang, Bo Xu, Ke-fei Dou, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|April 12, 2012
[Clinical outcome of patients undergoing emergent coronary artery bypass grafting following failed percutaneous coronary intervention in stent era]Han-jun Pei, Yong-jian Wu, Yue-jin Yang, et al.
Chinese Medical Journal|January 19, 2010
Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center databaseRun-lin Gao, Bo Xu, Ji-lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|October 12, 2013
[Clinical outcomes of rotational atherectomy followed by drug-eluting stenting via the transradial approach for the treatment of heavily calcified coronary lesions]Jin-gang Cui, Yue-jin Yang, Yong-jian Wu, et al.
Pageof 19